| Date Filed | Type | Description |
| 07/16/2010 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 07/07/2010 |
EFFECT
| Form EFFECT - |
| 07/07/2010 |
EFFECT
| Form EFFECT - |
| 07/07/2010 |
EFFECT
| Form EFFECT - |
| 07/06/2010 |
25-NSE
| Form 25-NSE - |
| 07/02/2010 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/02/2010 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/02/2010 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/02/2010 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 07/02/2010 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 07/02/2010 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 07/02/2010 |
8-K
| Quarterly results |
| 07/01/2010 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 07/01/2010 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 06/29/2010 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 06/21/2010 |
BW
| News Release Service Inadvertently Issues Hoax Press Release Identifying Javelin Pharmaceuticals as Issuer |
| 06/18/2010 |
BW
| Javelin Pharmaceuticals: US Supreme Court Split - Rules in Favor of Big Pharma |
| 06/17/2010 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 06/11/2010 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 06/11/2010 |
BW
| Javelin Receives $2 Million Loan from Hospira |
| 06/07/2010 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 06/04/2010 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
| 06/03/2010 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 05/26/2010 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 05/19/2010 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 05/10/2010 |
10-Q
| Quarterly Report for the period ended March 31, 2010 |
| 04/30/2010 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 04/28/2010 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 04/21/2010 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party |
| 04/19/2010 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party |
| 04/19/2010 |
BW
| Kendall Law Group Investigating Javelin Pharmaceuticals, Inc. Merger Agreement |
| 04/19/2010 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer |
| 04/19/2010 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob...|
Docs:
|
"Agreement and Plan of Merger, by and among Hospira, Inc, Discuss Acquisition Corporation and Javelin Pharmaceuticals, Inc",
"Loan and Security Agreement, by and among by and among Hospira, Inc, Javelin Pharmaceuticals, Inc., and Innovative Drug Delivery Systems, Inc",
"Javelin Pharmaceuticals Announces Termination of Merger Agreement with Myriad Pharmaceuticals, Cancels Special Meeting of Stockholders",
"HOSPIRA AND JAVELIN PHARMACEUTICALS ENTER INTO DEFINITIVE MERGER AGREEMENT FOR HOSPIRA TO ACQUIRE JAVELIN PHARMACEUTICALS; HOSPIRA WILL INITIATE TENDER OFFER" |
|
| 04/19/2010 |
BW
| Javelin Pharmaceuticals Announces Termination of Merger Agreement with Myriad Pharmaceuticals, Cancels Special Meeting of Stockholders |
|